Scientific Director
Proteus by Seqens, France
Olivier Vidalin (PhD), Scientific Director of Protéus by SEQENS
Protéus by SEQENS is a biotechnology company specialized in the discovery, engineering and production of enzymes for industrial applications, as well as in the development of innovative bioprocesses involving enzymes as biocatalysts.
Protéus is a subsidiary of the SEQENS Group, actor in the production of Active Pharmaceutical Ingredients and intermediates, fine and Specialty chemicals, and Cosmetics ingredients.
Protéus by SEQENS has developed a robust methodology platform, called Seqenzym®, for the rapid development of high performance biocatalytic processes relying on tailor-made enzymes.